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S8Objective: Repair of mitral regurgitation (MR) due to bileaflet prolapse poses many technical challenges. The
late outcomes after repair are also not well characterized in this population. Published series have often included
patients with mixed causes of prolapse and/or lack long-term echocardiographic follow-up. Myxomatous dis-
ease represents an important cause of bileaflet prolapse and MR and, thus, served as the focus of the present
study.
Methods: A total of 142 patients, mean age 60.4  13.2 years, underwent mitral valve (MV) repair of bileaflet
prolapse due to myxomatous disease from 2001 to 2010. Concomitant coronary artery bypass grafting was per-
formed in 16 patients (11%). All patients were followed up by a dedicated MV clinic with a follow-up interval
that extended up to 8.6 years.
Results: No hospital deaths occurred. Ring annuloplasty was used for all patients. Additional MV repair tech-
niques included chordal transfer in 73, a hybrid-flip-over technique in 23, polytetrafluoroethylene neochords in
26, edge-to-edge repair in 11, and commissuroplasty in 9. Prolapse involving more than 1 posterior leaflet scal-
lop was observed in 103 patients (73%), and prolapse of more than 1 anterior leaflet scallop was observed in 76
(54%). During follow-up, 4 patients had MR grade 2þor greater, and 2 patients required subsequent MV reop-
eration. The 5-year survival, freedom from recurrent MR (2þ), and freedom from MV reoperation was 95.2%
 2.8%, 92.6%  3.9%, and 94.0%  4.9%, respectively.
Conclusions:MV repair of bileaflet prolapse due to myxomatous disease is safe and durable. Successful repair
often requires a combination of surgical repair techniques. (J Thorac Cardiovasc Surg 2012;143:S8-11)Mitral valve (MV) repair is the preferred treatment of severe
mitral regurgitation (MR) and is performed with increasing
frequency compared with replacement.1 Successful repair
of posterior leaflet prolapse has been well reported1,2;
however, the long-term outcomes after repair of bileaflet
prolapse are not as well described.
Several expert MV repair centers have reported favorable
outcomes after MV repair of bileaflet prolapse.3-8 Freedom
from MV reoperation in these patients has ranged from
93% at 2 years to 96% at 10 years.3,4 MV repair in these
studies have included minimally invasive approaches,
chordal transfer, polytetrafluoroethylene neochords, and
edge-to-edge repair.3-9 Most of these studies, however,
have also included patients with mixed causes of MR, ande Division of Cardiac Surgerya and Department of Epidemiology and
unity Medicine,b University of Ottawa, Ottawa, Ontario, Canada
res: Vincent Chan, Marc Ruel, Sophia Chaudry, Stephane Lambert, and
ry G. Mesana have nothing to disclose with regard to commercial support.
d at The American Association for Thoracic Surgery Mitral Conclave, New
New York, May 5-6, 2011.
d for publicationMay 14, 2011; revisions received Dec 29, 2011; accepted for
ation Jan 16, 2012; available ahead of print Feb 3, 2012.
for reprints: Thierry G. Mesana, MD, PhD, University of Ottawa Heart In-
, 3402-40 Ruskin Street, Ottawa, ON K1Y 4W7 Canada (E-mail:
na@ottawaheart.ca).
23/$36.00
ht  2012 by The American Association for Thoracic Surgery
016/j.jtcvs.2012.01.046
The Journal of Thoracic and Cardiovascular Surgefew have addressed the outcomes in patients with
myxomatous disease alone.4,6 Long-term assessments of re-
current MR in this population are also lacking.
We therefore performed a follow-up study involving
142 patients who had undergone MV repair of bileaflet
prolapse due to myxomatous disease. The objective of
the present study was to describe our surgical approach
to bileaflet prolapse in these patients and to report our out-
comes with regard to survival, recurrent MR (2þ), and
MV reoperation.METHODS
Ethics Approval
The University of Ottawa Heart Institute has existing ethics approval
from its institutional research ethics board to anonymously publish data
prospectively collected before and after heart valve surgery. As such, indi-
vidual patient consent was waived.Patients
From 2001 to 2010, 142 patients underwent MV repair of bileaflet pro-
lapse due to myxomatous disease. These patients had typical myxoid de-
generation and excess tissue involving both leaflets. All patients
presented to the operating room with the intention to undergo MV repair.
During this period, 7 patients with myxomatous disease and bileaflet pro-
lapse (7 of 149, 95.3% repair rate) underwent MV replacement. An addi-
tional 151 patients with myxomatous disease were also referred for MV
repair during the study period, of whom 10 had isolated anterior leafletry c April 2012
Chan et al Mitral Valve ProlapseAbbreviations and Acronyms
MR ¼ mitral regurgitation
MV ¼ mitral valveprolapse and 141 had isolated posterior leaflet prolapse. Overall, 8 patients
with myxomatous disease and prolapse, bileaflet or otherwise, required
conversion to MV replacement (8 of 300, 97.3% repair rate).
Patients with Barlow’s disease had multiscallop prolapse and excess
leaflet tissue, along with elongated or thickened chords on direct valve in-
spection.9 The excess tissue had to be present in at least 2 anterior leaflet
scallops and 2 posterior leaflet scallops. All patients had severe mitral an-
nular dilation and received a ring annuloplasty 36 mm or greater. Echocar-
diographically, bulky, billowing leaflets were also observed.
Follow-up
The patients were assessed regularly in a dedicated MV clinic. The
patients were seen in the clinic 4 to 6 weeks after their initial surgery.
Subsequent follow-up information was obtained annually either
through direct clinic visits or telephone interviews. The clinic visits in-
cluded a history and physical examination, electrocardiogram, chest ra-
diograph, complete blood count, serum chemistries, and international
normalized ratio (when applicable). Echocardiographic follow-up was
also performed on all MV repair patients postoperatively at 1, 3 to 6,
and 12 months postoperatively. After 1 year, echocardiograms were
performed every 1 to 3 years or when clinically indicated. The mean
follow-up was 3.0  2.1 years (median, 2.7; maximum, 8.6). Valve-
related complications were defined and recorded according to estab-
lished criteria.10
Operative Technique
All MV repairs were performed with median sternotomy, cardiopul-
monary bypass, and cardioplegic arrest with cold blood cardioplegia.
MV annuloplasty was performed in all patients using the Medtronic Fu-
tureband in 114 (Medtronic, Minneapolis, Minn), Duran Ancore Band in
22 (Medtronic), and the Carpentier-Edwards Physio Annuloplasty Ring in
6 (Baxter Healthcare, Irvine, Calif). Posterior leaflet prolapse was cor-
rected with resection and sliding plasty in 96 patients (68%) to prevent
systolic anterior motion of the MV. The remaining 46 patients (32%) re-
ceived either a quadrangular or triangular resection without sliding plasty.
Anterior leaflet correction included native chordal transfer in 73 (51%)
and the hybrid flip-over technique in 23 patients (16%).11 In brief, the
hybrid flip-over technique is used in the setting of bileaflet prolapse. If
chordal transfer is not feasible after resection of the posterior leaflet, pol-
ytetrafluoroethylene neochordae are placed onto a remnant portion to the
posterior leaflet close to the annulus, with subsequent transfer of the pos-
terior leaflet tissue and neochordae to the anterior leaflet. This facilitates
measurement of the artificial neochordae to the level of the MV annulus
and provides a symmetric line of support to the anterior leaflet.11 The
posterior leaflet is then reconstructed after the sliding plasty. Chordal
transfer was the preferred approach to correct anterior leaflet prolapse
in this population and was used if secondary chords to the posterior leaf-
let were not thin, elongated, or calcified. The presence of ruptured chor-
dae did not necessarily preclude transfer of in situ chords. Isolated
chordal replacement with polytetrafluoroethylene neochordae was per-
formed in 15 patients and isolated edge-to-edge repair in 11 patients. An-
terolateral commissuroplasty was performed in 5 and posteromedial
commissuroplasty in 4. A combination of polytetrafluoroethylene neo-
chordae and an edge-to-edge repair was used in 5 patients. The median
annuloplasty ring size was 32 mm (range, 26–38). In all patients who un-
derwent MV repair, MR greater than 1þor a mean mitral gradient greater
than 5 mm Hg, determined intraoperatively, were indications forThe Journal of Thoracic and Caadditional MV intervention. A concomitant maze procedure was per-
formed for all patients with permanent atrial fibrillation or paroxysmal
atrial fibrillation present for at least 6 months before surgery.
Statistical Analysis
The data were imported and analyzed in Stata, version 11.1 (StataCorp,
College Station, Tex). Continuous variables are expressed as the mean 
standard deviation and categorical variables are described as a percentage
of the total. The Kaplan-Meiermethodwas used to assess survival, freedom
from recurrent MR (2þ), and freedom from MV reoperation.
RESULTS
Baseline Characteristics
The patient characteristics are listed in Table 1. The aver-
age age of this cohort was 60.4 13.2 years (range, 26–87),
and 23% had atrial fibrillation preoperatively. The left atrial
and left ventricle end-diastolic diameter was 48.8 8.1 mm
and 58.2  7.7 mm, respectively.
Barlow’s disease was observed in 42 patients (30%), and
76 patients (54%) had prolapse of more than 2 anterior leaf-
let scallops. Prolapse of at least 4 scallops was observed in
83 patients (58%) and prolapse of all 6 scallops in 18
(13%). All patients had bileaflet chordal elongation. Rup-
ture of the chords to the anterior leaflet occurred in 10 pa-
tients and rupture of chords to the posterior leaflet in 43.
Concomitant coronary artery bypass grafting was per-
formed in 16, aortic valve replacement in 1, maze procedure
in 20, and tricuspid valve repair in 15. Four patients under-
went MV repair by way of repeat sternotomy after previous
coronary artery bypass grafting.
Survival
No intraoperative or hospital deaths occurred. Six late
deaths occurred during follow-up from cerebrovascular ac-
cident in 1, congestive heart failure in 2, lower gastrointes-
tinal bleeding in 1, myocardial infarction in 1, and unknown
in 1. The 5-year survival was 95.2%  2.8% (Figure 1).
Freedom From Recurrent MR (2þ) and MV
Reoperation
Recurrent MR (2þ) was observed in 4 patients (3%) after
repair, of whom 1 hadmore than 2þMR. Freedom from recur-
rent MR (2þ) was 97.5%  1.7% at 1 year and 92.6% 
3.9% at 5 years (Figure 1). In patients whose repair involved
native chordal transfer, the 5-year freedom from recurrent
MR (2þ)was 93.1% 4.8%. Therewere 2MVreoperations
in the present series. One patient had recurrent 4þMR 2.2
months after the initial repair due to failure of the polytetra-
fluoroethylene chordae to the anterior leaflet. These chordae
were found to be torn on reoperation. He subsequently under-
went mechanical MV replacement. The other patient devel-
oped severe mitral stenosis in addition to moderate MR
secondary to pannus in-growth surrounding his full-ring annu-
loplasty. He underwent successful repeat repair of his MV 4.5
years after his initial operation. The 5-year freedom fromMV
reoperation was 94.0% 4.9%.rdiovascular Surgery c Volume 143, Number 4S S9
TABLE 1. Patient, echocardiographic, and operative characteristics
Characteristic Value
Patient characteristics
Age (y) 60.4  13.2
Atrial fibrillation* 33 (23)
Diabetes mellitus 2 (1)
Female gender 36 (25)
NYHA class III-IV 20 (14)
Preoperative echocardiographic characteristics
Left atrial diameter (mm) 48.8  8.1
LV ejection fraction 50% 120 (85)
LV end-diastolic diameter (mm) 58.2  7.7
LV end-systolic diameter (mm) 35.6  8.4
Preoperative RVSP classy
I 65 (46)
II 44 (31)
III 21 (15)
IV 12 (8)
Mitral valve characteristics
Barlow’s diseasez 42 (30)
Prolapse of 2 anterior leaflet scallops 76 (54)
Prolapse of 2 posterior leaflet scallops 103 (73)
Prolapsed scallops (n)
4 51 (36)
5 14 (10)
6 18 (13)
Operative characteristics
Concomitant CABG 16 (11)
Concomitant aortic valve replacement 1 (0.7)
Concomitant maze procedurex 20 (14)
Concomitant tricuspid valve repair 15 (11)
Reoperative sternotomy 4 (3)
Data in parentheses are percentages. NYHA, New York Heart Association; LV, left
ventricle; CABG, coronary artery bypass grafting; RVSP, right ventricle systolic pres-
sure. *Included permanent and known paroxysmal atrial fibrillation preoperatively.
yRVSP class I, RVSP<35 mm Hg; class II, RVSP 35–44 mm Hg; class III, RVSP
45–60 mmHg; class IV, RVSP>60 mmHg. zPatients with Barlow’s disease had mul-
tiscallop prolapse and excess leaflet tissue, along with elongated or thickened chords
on direct valve inspection. Excess tissue required in 2 anterior leaflet scallops and
2 posterior leaflet scallops. All patients had severe mitral annular dilation and re-
ceived a ring annuloplasty, size 36 mm. Echocardiographically, bulky, billowing
leaflets were also observed. xIncluded left-sided lesions only performed with Med-
tronic Cardioblate irrigated unipolar radiofrequency system (Medtronic, Minneapo-
lis, Minn). A concomitant maze procedure was performed for all patients with
permanent atrial fibrillation or paroxysmal atrial fibrillation present for 6 months
before surgery.
FIGURE 1. Outcomes after mitral valve repair of myxomatous bileaflet
prolapse. Overall survival, freedom from recurrent MR (2þ), and freedom
from mitral valve reoperation shown. At follow-up, 6 patients died, 4 pa-
tients had recurrent MR (2þ), and 2 patients underwent mitral valve reop-
eration. The mean clinical follow-up interval was 3.0  2.1 years, and the
mean echocardiographic follow-up interval was 2.6  2.1 years.
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One fatal cerebrovascular accident and one fatal lower
gastrointestinal bleeding episode, mentioned in the previ-
ous section, were observed during follow-up. No cases of
endocarditis or additional cases of hemorrhage or thrombo-
embolism were observed. The 5-year freedom from hemor-
rhage and thromboembolism was 98.9%  1.1% and
98.3%  1.7%, respectively.
DISCUSSION
In the present study, we described our experience with
MV repair of bileaflet prolapse due to myxomatous disease.S10 The Journal of Thoracic and Cardiovascular SurgThe demographics of the patients in the present study
were similar to others describingMV repair of myxomatous
disease. Published series have involved cohorts aged 40 to
60 years.4,6 Similar to our series, others also had one third
of patients with preoperative atrial fibrillation, and
approximately 15% required concomitant coronary artery
bypass grafting.4,6 Patients with Barlow’s disease
typically present with multiscallop prolapse,4,6,9 and in
the present study, one half had prolapse of more than 2
anterior leaflet scallops and three quarters had prolapse of
more than 2 posterior leaflet scallops. Experienced centers
have also reported 0% 30-day mortality.4,6
Our approach to MV repair in patients with bileaflet pro-
lapse and myxomatous disease involves a combination of
surgical techniques. Anyanwu and Adams9 emphasized
the importance of appropriate annuloplasty sizing. Al-
though several annuloplasty systems were used in the pres-
ent study, the C-shaped, semirigid, Medtronic Futureband
(Medtronic) has been exclusively used at our institution
since 2004. Our preferred repair technique in patients
with bileaflet prolapse is chordal transfer with associated
posterior leaflet plication. The 5-year freedom from recur-
rent MR (2þ) was 93% for patients who received chordal
transfer as a part of the MV repair. To our knowledge, no
series have described the long-term outcomes after chordal
transfer in patients with bileaflet prolapse.
However, native chordae that are not thin, elongated, or cal-
cified might not be available. In these instances, we use poly-
tetrafluoroethylene chords or an edge-to-edge repair. David
and colleagues4 reported 96% freedom fromMV reoperation
in patients using primarily polytetrafluoroethylene neochor-
dae. Others have also reported favorable early results with ar-
tificial neochords.3,5,8 In the present study, the 1 patient whoery c April 2012
Chan et al Mitral Valve Prolapsedeveloped recurrent 4þ MR and required MV reoperation
developed failure of polytetrafluoroethylene chordae to the
anterior leaflet. These chords were found to be torn on
reoperation. However, the results from the present series also
suggest favorable durability with artificial chordae. The
edge-to-edge repair was used primarily in older patients with
isolated A2-P2 prolapse and associated annular calcification.
In patients with extensive anterior leaflet prolapse with-
out adequate native chords, we used the hybrid flip-over
technique.11 This involves placement of polytetrafluoro-
ethylene neochordae to a portion of the posterior leaflet,
which is then transferred to the anterior leaflet. This facili-
tates measurement of neochordae to the height of the MV
annulus, while providing a broad area of support to the an-
terior leaflet.11 In the present series, the hybrid flip-over
technique was used in 16% of the patients.
Valve-related complications were rarely observed during
study follow-up.10 These data therefore emphasize the clin-
ical benefits of MV repair over replacement.Study Limitations
These data constitute a single-center experience with
midterm follow-up. The risk factors associated with sur-
vival, recurrent MR, and MV reoperation were not deter-
mined owing to the low number of events.
CONCLUSIONS
MV repair of bileaflet prolapse due to myxomatous dis-
ease is safe and durable. Successful repair often requires
a combination of surgical repair techniques.The Journal of Thoracic and CarReferences
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